Anne‐Marie Lambeir

9.4k citations

177 papers · 7.8k indexed · 1 hit paper · h-index 47

Oncology top 0.5%
Molecular Biology top 2%
Cellular and Molecular Neuroscience top 0.5%
Endocrinology, Diabetes and Metabolism top 0.5%
Surgery top 5%

Co-authors: Ingrid De Meester Simon Scharpé Christine Durinx Koen Augustyns Pieter Van der Veken Achiel Haemers Jurgen Joossens Paul Proost
Topics: Peptidase Inhibition and Analysis (94 papers)Neuropeptides and Animal Physiology (65 papers)Diabetes Treatment and Management (23 papers)
Cited by: Oncology Cellular and Molecular Neuroscience Endocrinology, Diabetes and Metabolism
Journals: Journal of Biological Chemistry Blood PLoS ONE
Partner nations: Belgium United States Canada

In The Last Decade

Anne‐Marie Lambeir

176 papers receiving 7.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Dipeptidyl-Peptidase IV from Bench to Bedside: An Update on Structural Properties, Functions, and Clinical Aspects of the Enzyme DPP IV

2003 809 citations Anne‐Marie Lambeir, Simon Scharpé et al. profile →

Peers

Countries citing papers authored by Anne‐Marie Lambeir

Since Specialization

Citations

This map shows the geographic impact of Anne‐Marie Lambeir's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anne‐Marie Lambeir with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anne‐Marie Lambeir more than expected).

Fields of papers citing papers by Anne‐Marie Lambeir

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anne‐Marie Lambeir. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anne‐Marie Lambeir. The network helps show where Anne‐Marie Lambeir may publish in the future.

Co-authorship network of co-authors of Anne‐Marie Lambeir

This figure shows the co-authorship network connecting the top 25 collaborators of Anne‐Marie Lambeir. A scholar is included among the top collaborators of Anne‐Marie Lambeir based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anne‐Marie Lambeir. Anne‐Marie Lambeir is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Human Transmembrane Serine Protease 2 (TMPRSS2) on Human Seminal Fluid Extracellular Vesicles Is Proteolytically Active 2025 ·Journal of Extracellular Vesicles ·(unknown),(unknown),Pascale Berckmans,(unknown),Koen Augustyns,Isabel Pintelon,Maya Berg,Pieter Van Wielendaele,Anne‐Marie Lambeir,Yann G.‐J. Sterckx,Inge Nelissen,Ingrid De Meester	1
2	Effects of Detergent on α-Synuclein Structure: A Native MS-Ion Mobility Study 2020 ·International Journal of Molecular Sciences ·Rani Moons,(unknown),Stuart Maudsley,Filip Lemière,Anne‐Marie Lambeir,Frank Sobott	13
3	Selective inhibition of carboxypeptidase U may reduce microvascular thrombosis in rat experimental stroke 2020 ·Journal of Thrombosis and Haemostasis ·(unknown),William Boisseau,(unknown),Lucas Di Meglio,Stéphane Loyau,Anne‐Marie Lambeir,Célina Ducroux,Martine Jandrot‐Perrus,Jean‐Baptiste Michel,Mikaël Mazighi,Dirk Hendriks,Jean‐Philippe Désilles	6
4	Efforts towards an On‐Target Version of the Groebke–Blackburn–Bienaymé (GBB) Reaction for Discovery of Druglike Urokinase (uPA) Inhibitors 2019 ·Chemistry - A European Journal ·(unknown),(unknown),Dries Van Rompaey,Anne‐Marie Lambeir,Koen Augustyns,Hans De Winter,Pieter Van der Veken	12
5	Newly developed serine protease inhibitors decrease visceral hypersensitivity in a post‐inflammatory rat model for irritable bowel syndrome 2018 ·British Journal of Pharmacology ·Hannah Ceuleers,Nikita Hanning,(unknown),(unknown),Jurgen Joossens,Pieter Van der Veken,Sven Francque,(unknown),Anne‐Marie Lambeir,Joris G. De Man,Jean‐Pierre Timmermans,Koen Augustyns,Ingrid De Meester,Benedicte Y. De Winter	36
6	Dynamics and ligand-induced conformational changes in human prolyl oligopeptidase analyzed by hydrogen/deuterium exchange mass spectrometry 2017 ·Scientific Reports ·Alexandra Tsirigotaki,Roos Van Elzen,Pieter Van der Veken,Anne‐Marie Lambeir,Anastassios Economou	20
7	Regulation of intestinal permeability: The role of proteases 2017 ·World Journal of Gastroenterology ·(unknown),Hannah Ceuleers,(unknown),(unknown),Jurgen Joossens,Koen Augustyns,Anne‐Marie Lambeir,Ingrid De Meester,Joris G. De Man,Benedicte Y. De Winter	139
8	Inhibitor screening and enzymatic activity determination for autophagy target Atg4B using a gel electrophoresis-based assay 2016 ·European Journal of Medicinal Chemistry ·(unknown),Mandy O. J. Grootaert,(unknown),(unknown),Ria Roelandt,Jurgen Joossens,Anne‐Marie Lambeir,Guido R.Y. De Meyer,Wim Declercq,Koen Augustyns,Wim Martinet,Pieter Van der Veken	12
9	Plasma levels of carboxypeptidase U (CPU, CPB2 or TAFIa) are elevated in patients with acute myocardial infarction 2015 ·Journal of Thrombosis and Haemostasis ·(unknown),Johan Bosmans,Pieter Van der Veken,(unknown),Anne‐Marie Lambeir,Dirk Hendriks	15
10	Acylated Gly-(2-cyano)pyrrolidines as inhibitors of fibroblast activation protein (FAP) and the issue of FAP/prolyl oligopeptidase (PREP)-selectivity 2012 ·Bioorganic & Medicinal Chemistry Letters ·O.V. Ryabtsova,Koen Jansen,(unknown),Jurgen Joossens,Jonathan D. Cheng,Anne‐Marie Lambeir,Ingrid De Meester,Koen Augustyns,Pieter Van der Veken	47
11	Prolyl oligopeptidase stimulates the aggregation of α-synuclein 2008 ·Peptides ·Inger Brandt,Melanie Gérard,Kjell Sergeant,Bart Devreese,Veerle Baekelandt,Koen Augustyns,Simon Scharpé,Yves Engelborghs,Anne‐Marie Lambeir	76
12	Inhibitors of dipeptidyl peptidase 8 and dipeptidyl peptidase 9. Part 2: Isoindoline containing inhibitors 2008 ·Bioorganic & Medicinal Chemistry Letters ·(unknown),Pieter Van der Veken,Véronique Dubois,(unknown),Anne‐Marie Lambeir,Xin Chen,Achiel Haemers,Simon Scharpé,Ingrid De Meester,Koen Augustyns	62
13	Carboxypeptidase M: Multiple alliances and unknown partners 2008 ·Clinica Chimica Acta ·Kathleen Deiteren,Dirk Hendriks,Simon Scharpé,Anne‐Marie Lambeir	41
14	Dipeptidyl peptidase II and leukocyte cell death 2006 ·Biochemical Pharmacology ·Marie-Berthe Maes,Wim Martinet,D. Schrijvers,Pieter Van der Veken,Guido R.Y. De Meyer,Koen Augustyns,Anne‐Marie Lambeir,Simon Scharpé,Ingrid De Meester	15
15	A kinetic study of glucagon-like peptide-1 and glucagon-like peptide-2 truncation by dipeptidyl peptidase IV, in vitro 2002 ·Biochemical Pharmacology ·Anne‐Marie Lambeir,Paul Proost,Simon Scharpé,Ingrid De Meester	28
16	Structural and mutagenesis studies of leishmania triosephosphate isomerase: a point mutation can convert a mesophilic enzyme into a superstable enzyme without losing catalytic power 1999 ·Protein Engineering Design and Selection ·John C. Williams,Johan Zeelen,Gitte Neubauer,Gert Vriend,Jan Backmann,Paul A.M. Michels,Anne‐Marie Lambeir,R.K. Wierenga	97
17	Amino-terminal Truncation of Chemokines by CD26/Dipeptidyl-peptidase IV 1998 ·Journal of Biological Chemistry ·Paul Proost,Ingrid De Meester,Dominique Schols,Sofie Struyf,Anne‐Marie Lambeir,Anja Wuyts,Ghislain Opdenakker,Erik De Clercq,Simon Scharpé,Jo Van Damme	226
18	Comparative properties of a factor-xa inhibitor, 4c2 (an aprotonin analog), heparin and hirudin in a hamster femoral vein platelet-rich mural thrombosis model 1993 ·Thrombosis and Haemostasis ·JM Stassen,Hans Deckmyn,Ingrid Vreys,Anne‐Marie Lambeir	2
19	The adaptability of the active site of trypanosomal triosephosphate isomerase as observed in the crystal structures of three different complexes 1991 ·Proteins Structure Function and Bioinformatics ·M.E.M. Noble,Rik K. Wierenga,Anne‐Marie Lambeir,Fred R. Opperdoes,A.M.W.H. Thunnissen,Kor H. Kalk,H. Groendijk,Wim G. J. Hol	72
20	Glucosephosphate isomerase from Trypanosoma brucei 1989 ·European Journal of Biochemistry ·(unknown),(unknown),Rik K. Wierenga,Anne‐Marie Lambeir,J. Van Beeumen,Fred R. Opperdoes,Paul A.M. Michels	94

About Anne‐Marie Lambeir

Anne‐Marie Lambeir is a scholar working on Cellular and Molecular Neuroscience, Oncology and Endocrinology, Diabetes and Metabolism, having authored 177 papers that have together received 7.8k indexed citations. Recurring topics across this work include Peptidase Inhibition and Analysis (94 papers), Neuropeptides and Animal Physiology (65 papers) and Diabetes Treatment and Management (23 papers). The work is most often cited by research in Oncology (3.8k citations), Cellular and Molecular Neuroscience (2.0k citations) and Endocrinology, Diabetes and Metabolism (1.5k citations). Anne‐Marie Lambeir has collaborated with scholars based in Belgium, United States and Canada. Frequent co-authors include Ingrid De Meester, Simon Scharpé, Christine Durinx, Koen Augustyns, Pieter Van der Veken, Achiel Haemers, Jurgen Joossens, Paul Proost, H. Brian Dunford and Rik K. Wierenga. Their work appears in journals such as Journal of Biological Chemistry, Blood and PLoS ONE.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact